K M C Speciality Hospitals (India) valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024FY23Mar 2023FY22Mar 2022FY21Mar 2021FY20 and earlierAlpha Plus
Price multiples — at each FY-end close
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
76.40×————
13.10×————
60.41×————
Yield
1.3%————
1.7%————
Reference — adjusted share basis
₹142.10————
₹1.86₹1.86₹1.63₹1.45₹0.78
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹142.10

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,321 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Current
last close
Price Multiples — at each FY-end close
P/E————76.40
P/Sales————13.10
Price to Free Cash Flow————60.41
Yield
Earnings Yield %————1.31
FCF Yield %————1.66
Reference — adjusted share basis
Price (FY-end close, adj.)————142.10
EPS (adj.)0.781.451.631.861.86
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.